Synergistic induction of apoptosis by the Bcl‐2 inhibitor ABT‐737 and imatinib mesylate in gastrointestinal stromal tumor cells

Background: Although imatinib mesylate has revolutionized the management of patients with gastrointestinal stromal tumor (GIST), resistance and progression almost inevitably develop with long‐term monotherapy. To enhance imatinib‐induced cytotoxicity and overcome imatinib‐resistance in GIST cells, w...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Mol Oncol
Glavni autori: Reynoso, David, Nolden, Laura K., Yang, Dan, Dumont, Sarah N., Conley, Anthony P., Dumont, Amaury G.P., Zhou, Kim, Duensing, Anette, Trent, Jonathan C.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2010
Teme:
Papers
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528266/
https://ncbi.nlm.nih.gov/pubmed/21115411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2010.10.003
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items